• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

Becoming a mother despite pregnancy-induced heart failure

February 13, 2025
in Medical Research
Reading Time: 4 mins read
A A
0
Becoming a mother despite pregnancy-induced heart failure
7
SHARES
16
VIEWS
Share on FacebookShare on Twitter


Becoming a mother despite pregnancy-induced heart failure
Leaders in research into pregnancy-related cardiac insufficiency (PPCM) for many years: Professor Denise Hilfiker-Kleiner and Professor Dr. Johann Bauersachs. Credit: Karin Kaiser/MHH

Peripartum cardiac insufficiency (PPCM) is a rare but life-threatening condition that can affect previously heart-healthy women a few weeks before or after the birth of a child. For unknown reasons, the left ventricle is severely restricted in its pumping action.

The Department of Cardiology and Angiology at the Hannover Medical School (MHH) is Europe’s leading PPCM center and provides care for patients in a specialized outpatient clinic with a multi-professional team from the fields of cardiology, obstetrics and neonatology.

The disease is not only treated in the clinic, but is also one of its research priorities, with a very large PPCM registry containing data and biomaterials from more than 200 patients.

MHH President Professor Denise Hilfiker-Kleiner established the research field at the MHH more than 20 years ago and, together with clinic director Professor Dr. Johann Bauersachs and their teams, published fundamental scientific findings about PPCM.

In 2007, Professor Hilfiker-Kleiner and her research group discovered that in affected women, the breastfeeding hormone prolactin is broken down into a metabolite that damages blood vessels, causing heart failure.

Various pilot studies and case reports suggested that blocking prolactin with the weaning drug bromocriptine promotes the healing of PPCM. Ten years later, a scientific study showed that administering bromocriptine for seven days in addition to heart failure therapy is sufficient.

In addition to new treatment options, researchers are addressing the question of how high the risk is of recurrence or progression of heart failure in mothers who become pregnant again after PPCM.

Professor Hilfiker-Kleiner and Professor Bauersachs have now published new studies on both topics in the European Heart Journal.

The first study shows that treatment with bromocriptine is effective as an addition to the usual therapy for heart failure without increasing the risk of thrombosis.

The second study shows that even women with mild persistent heart failure can have a subsequent pregnancy with close cardiological care.

Bromocriptine improves heart health

PPCM affects one in 1,500 to 2,000 pregnant women. This life-threatening heart condition strikes without warning and can quickly lead to severe heart failure and even death.

The symptoms are similar to those that often occur towards the end of a pregnancy and shortly after delivery: exhaustion, shortness of breath, coughing, weight gain, particularly due to fluid retention in the lungs and legs, and tachycardia.

PPCM is therefore often not recognized and probably occurs more frequently than assumed. However, heart failure can be clearly demonstrated with the help of a cardiac ultrasound and certain marker proteins in the blood. When treated in time, the heart often recovers completely, but heart failure may also remain.

“Bromocriptine is a promising treatment option for PPCM in addition to therapy with the medications usually used for heart failure,” says Professor Hilfiker-Kleiner.

“In a large, global PPCM registry with 552 PPCM patients, we confirmed the efficacy of bromocriptine and showed that it significantly improves maternal cardiac health.”

Case reports of an increased risk of vascular occlusion during treatment with the weaning drug have not been confirmed. “These data not only confirm the efficacy but also the safety of our therapeutic approach,” explains the PPCM expert.

Lower risk for subsequent pregnancy than expected

The second study addressed the question of whether women with PPCM should generally be advised against becoming pregnant again. The participants were patients from the Global PPCM Registry of the European Society of Cardiology.

“In previous studies, we showed that patients who become pregnant again with severely reduced heart function have a higher risk of a deterioration in the pumping function of the heart in a subsequent pregnancy,” says Professor Bauersachs.

“However, in the current study, we found that the risk of the mothers becoming seriously ill or even dying was lower than expected.” Even in women who continued to suffer from mild heart failure after childbirth, the condition of the heart did not worsen after a subsequent pregnancy.

“The data from our latest study suggest that a subsequent pregnancy in PPCM patients with a justifiable risk seems possible not only when heart function has recovered, but also when it is only slightly restricted,” says Professor Bauersachs.

However, this relaxation can only be considered if the patient continues to be cared for by an experienced, interdisciplinary medical team and receives appropriate drug treatment.

“This is the case in our specialized outpatient clinic, where we have been successfully treating such women for years,” emphasizes Professor Bauersachs.

More information:
Peter van der Meer et al, Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registry, European Heart Journal (2024). DOI: 10.1093/eurheartj/ehae559

Karen Sliwa et al, Pregnancies in women after peri-partum cardiomyopathy: the global European Society of Cardiology EuroObservational Research Programme Peri-Partum Cardiomyopathy Registry, European Heart Journal (2025). DOI: 10.1093/eurheartj/ehaf006

Provided by
Medizinische Hochschule Hannover

Citation:
Becoming a mother despite pregnancy-induced heart failure (2025, February 13)
retrieved 13 February 2025
from https://medicalxpress.com/news/2025-02-mother-pregnancy-heart-failure.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



Becoming a mother despite pregnancy-induced heart failure
Leaders in research into pregnancy-related cardiac insufficiency (PPCM) for many years: Professor Denise Hilfiker-Kleiner and Professor Dr. Johann Bauersachs. Credit: Karin Kaiser/MHH

Peripartum cardiac insufficiency (PPCM) is a rare but life-threatening condition that can affect previously heart-healthy women a few weeks before or after the birth of a child. For unknown reasons, the left ventricle is severely restricted in its pumping action.

The Department of Cardiology and Angiology at the Hannover Medical School (MHH) is Europe’s leading PPCM center and provides care for patients in a specialized outpatient clinic with a multi-professional team from the fields of cardiology, obstetrics and neonatology.

The disease is not only treated in the clinic, but is also one of its research priorities, with a very large PPCM registry containing data and biomaterials from more than 200 patients.

MHH President Professor Denise Hilfiker-Kleiner established the research field at the MHH more than 20 years ago and, together with clinic director Professor Dr. Johann Bauersachs and their teams, published fundamental scientific findings about PPCM.

In 2007, Professor Hilfiker-Kleiner and her research group discovered that in affected women, the breastfeeding hormone prolactin is broken down into a metabolite that damages blood vessels, causing heart failure.

Various pilot studies and case reports suggested that blocking prolactin with the weaning drug bromocriptine promotes the healing of PPCM. Ten years later, a scientific study showed that administering bromocriptine for seven days in addition to heart failure therapy is sufficient.

In addition to new treatment options, researchers are addressing the question of how high the risk is of recurrence or progression of heart failure in mothers who become pregnant again after PPCM.

Professor Hilfiker-Kleiner and Professor Bauersachs have now published new studies on both topics in the European Heart Journal.

The first study shows that treatment with bromocriptine is effective as an addition to the usual therapy for heart failure without increasing the risk of thrombosis.

The second study shows that even women with mild persistent heart failure can have a subsequent pregnancy with close cardiological care.

Bromocriptine improves heart health

PPCM affects one in 1,500 to 2,000 pregnant women. This life-threatening heart condition strikes without warning and can quickly lead to severe heart failure and even death.

The symptoms are similar to those that often occur towards the end of a pregnancy and shortly after delivery: exhaustion, shortness of breath, coughing, weight gain, particularly due to fluid retention in the lungs and legs, and tachycardia.

PPCM is therefore often not recognized and probably occurs more frequently than assumed. However, heart failure can be clearly demonstrated with the help of a cardiac ultrasound and certain marker proteins in the blood. When treated in time, the heart often recovers completely, but heart failure may also remain.

“Bromocriptine is a promising treatment option for PPCM in addition to therapy with the medications usually used for heart failure,” says Professor Hilfiker-Kleiner.

“In a large, global PPCM registry with 552 PPCM patients, we confirmed the efficacy of bromocriptine and showed that it significantly improves maternal cardiac health.”

Case reports of an increased risk of vascular occlusion during treatment with the weaning drug have not been confirmed. “These data not only confirm the efficacy but also the safety of our therapeutic approach,” explains the PPCM expert.

Lower risk for subsequent pregnancy than expected

The second study addressed the question of whether women with PPCM should generally be advised against becoming pregnant again. The participants were patients from the Global PPCM Registry of the European Society of Cardiology.

“In previous studies, we showed that patients who become pregnant again with severely reduced heart function have a higher risk of a deterioration in the pumping function of the heart in a subsequent pregnancy,” says Professor Bauersachs.

“However, in the current study, we found that the risk of the mothers becoming seriously ill or even dying was lower than expected.” Even in women who continued to suffer from mild heart failure after childbirth, the condition of the heart did not worsen after a subsequent pregnancy.

“The data from our latest study suggest that a subsequent pregnancy in PPCM patients with a justifiable risk seems possible not only when heart function has recovered, but also when it is only slightly restricted,” says Professor Bauersachs.

However, this relaxation can only be considered if the patient continues to be cared for by an experienced, interdisciplinary medical team and receives appropriate drug treatment.

“This is the case in our specialized outpatient clinic, where we have been successfully treating such women for years,” emphasizes Professor Bauersachs.

More information:
Peter van der Meer et al, Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registry, European Heart Journal (2024). DOI: 10.1093/eurheartj/ehae559

Karen Sliwa et al, Pregnancies in women after peri-partum cardiomyopathy: the global European Society of Cardiology EuroObservational Research Programme Peri-Partum Cardiomyopathy Registry, European Heart Journal (2025). DOI: 10.1093/eurheartj/ehaf006

Provided by
Medizinische Hochschule Hannover

Citation:
Becoming a mother despite pregnancy-induced heart failure (2025, February 13)
retrieved 13 February 2025
from https://medicalxpress.com/news/2025-02-mother-pregnancy-heart-failure.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.


Tags: Health ResearchHealth Research NewsHealth ScienceMedicine ResearchMedicine Research NewsMedicine Science
Previous Post

Israel threatens ‘intense fighting’ in Gaza if Hamas doesn’t release hostages

Next Post

Five Things You Should Know About Reusable Grocery Bags

Related Posts

Higher linoleic acid levels linked to lower heart disease and diabetes risk

Higher linoleic acid levels linked to lower heart disease and diabetes risk

June 1, 2025
4
CAR T cell therapy

Dual-target CAR T cell therapy slows growth of aggressive brain cancer

June 1, 2025
4
Next Post
Four reusable bags in a row

Five Things You Should Know About Reusable Grocery Bags

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
The Rev Zolile Mbali obituary

The Rev Zolile Mbali obituary

June 1, 2025

‘Liberals are engaging in bad faith’: Feminist Conservatives clap back

June 1, 2025
Aid ship set sail from Sicily with aid for Gaza

Aid ship set sail from Sicily with aid for Gaza

June 1, 2025
Spike in steel tariffs could imperil Trump promise of lower grocery prices

Spike in steel tariffs could imperil Trump promise of lower grocery prices todayheadline

June 1, 2025

Recent News

The Rev Zolile Mbali obituary

The Rev Zolile Mbali obituary

June 1, 2025
0

‘Liberals are engaging in bad faith’: Feminist Conservatives clap back

June 1, 2025
4
Aid ship set sail from Sicily with aid for Gaza

Aid ship set sail from Sicily with aid for Gaza

June 1, 2025
5
Spike in steel tariffs could imperil Trump promise of lower grocery prices

Spike in steel tariffs could imperil Trump promise of lower grocery prices todayheadline

June 1, 2025
9

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

The Rev Zolile Mbali obituary

The Rev Zolile Mbali obituary

June 1, 2025

‘Liberals are engaging in bad faith’: Feminist Conservatives clap back

June 1, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co